Nf1 haploinsufficiency alters myeloid lineage commitment and function, leading to deranged skeletal homeostasis

Steven D. Rhodes, Hao Yang, Ruizhi Dong, Keshav Menon, Yongzheng He, Zhaomin Li, Shi Chen, Karl W. Staser, Li Jiang, Xiaohua Wu, Xianlin Yang, Xianghong Peng, Khalid S. Mohammad, Theresa A. Guise, Mingjiang Xu, Feng-Chun Yang

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Although nullizygous loss of NF1 leads to myeloid malignancies, haploinsufficient loss of NF1 (Nf1) has been shown to contribute to osteopenia and osteoporosis which occurs in approximately 50% of neurofibromatosis type 1 (NF1) patients. Bone marrow mononuclear cells of haploinsufficient NF1 patients and Nf1<sup>+/-</sup> mice exhibit increased osteoclastogenesis and accelerated bone turnover; however, the culprit hematopoietic lineages responsible for perpetuating these osteolytic manifestations have yet to be elucidated. Here we demonstrate that conditional inactivation of a single Nf1 allele within the myeloid progenitor cell population (Nf1-LysM) is necessary and sufficient to promote multiple osteoclast gains-in-function, resulting in enhanced osteoclastogenesis and accelerated osteoclast bone lytic activity in response to proresorptive challenge in vivo. Surprisingly, mice conditionally Nf1 heterozygous in mature, terminally differentiated osteoclasts (Nf1-Ctsk) do not exhibit any of these skeletal phenotypes, indicating a critical requirement for Nf1 haploinsufficiency at a more primitive/progenitor stage of myeloid development in perpetuating osteolytic activity. We further identified p21Ras-dependent hyperphosphorylation of Pu.1 within the nucleus of Nf1 haploinsufficient myelomonocytic osteoclast precursors, providing a novel therapeutic target for the potential treatment of NF1 associated osteolytic manifestations.

Original languageEnglish (US)
Pages (from-to)1840-1851
Number of pages12
JournalJournal of Bone and Mineral Research
Volume30
Issue number10
DOIs
StatePublished - Oct 1 2015
Externally publishedYes

Fingerprint

Haploinsufficiency
Neurofibromatosis 1
Osteoclasts
Homeostasis
Osteogenesis
Myeloid Progenitor Cells
Bone Remodeling
Metabolic Bone Diseases
Bone Marrow Cells
Osteoporosis
Alleles
Phenotype
Bone and Bones
Therapeutics
Population
Neoplasms

Keywords

  • animal models
  • cells of bone
  • diseases and disorders of/related to bone
  • genetic animal models
  • osteoclasts
  • osteoporosis

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Nf1 haploinsufficiency alters myeloid lineage commitment and function, leading to deranged skeletal homeostasis. / Rhodes, Steven D.; Yang, Hao; Dong, Ruizhi; Menon, Keshav; He, Yongzheng; Li, Zhaomin; Chen, Shi; Staser, Karl W.; Jiang, Li; Wu, Xiaohua; Yang, Xianlin; Peng, Xianghong; Mohammad, Khalid S.; Guise, Theresa A.; Xu, Mingjiang; Yang, Feng-Chun.

In: Journal of Bone and Mineral Research, Vol. 30, No. 10, 01.10.2015, p. 1840-1851.

Research output: Contribution to journalArticle

Rhodes, SD, Yang, H, Dong, R, Menon, K, He, Y, Li, Z, Chen, S, Staser, KW, Jiang, L, Wu, X, Yang, X, Peng, X, Mohammad, KS, Guise, TA, Xu, M & Yang, F-C 2015, 'Nf1 haploinsufficiency alters myeloid lineage commitment and function, leading to deranged skeletal homeostasis', Journal of Bone and Mineral Research, vol. 30, no. 10, pp. 1840-1851. https://doi.org/10.1002/jbmr.2538
Rhodes, Steven D. ; Yang, Hao ; Dong, Ruizhi ; Menon, Keshav ; He, Yongzheng ; Li, Zhaomin ; Chen, Shi ; Staser, Karl W. ; Jiang, Li ; Wu, Xiaohua ; Yang, Xianlin ; Peng, Xianghong ; Mohammad, Khalid S. ; Guise, Theresa A. ; Xu, Mingjiang ; Yang, Feng-Chun. / Nf1 haploinsufficiency alters myeloid lineage commitment and function, leading to deranged skeletal homeostasis. In: Journal of Bone and Mineral Research. 2015 ; Vol. 30, No. 10. pp. 1840-1851.
@article{0291517520dd40c080beb26c25739101,
title = "Nf1 haploinsufficiency alters myeloid lineage commitment and function, leading to deranged skeletal homeostasis",
abstract = "Although nullizygous loss of NF1 leads to myeloid malignancies, haploinsufficient loss of NF1 (Nf1) has been shown to contribute to osteopenia and osteoporosis which occurs in approximately 50{\%} of neurofibromatosis type 1 (NF1) patients. Bone marrow mononuclear cells of haploinsufficient NF1 patients and Nf1+/- mice exhibit increased osteoclastogenesis and accelerated bone turnover; however, the culprit hematopoietic lineages responsible for perpetuating these osteolytic manifestations have yet to be elucidated. Here we demonstrate that conditional inactivation of a single Nf1 allele within the myeloid progenitor cell population (Nf1-LysM) is necessary and sufficient to promote multiple osteoclast gains-in-function, resulting in enhanced osteoclastogenesis and accelerated osteoclast bone lytic activity in response to proresorptive challenge in vivo. Surprisingly, mice conditionally Nf1 heterozygous in mature, terminally differentiated osteoclasts (Nf1-Ctsk) do not exhibit any of these skeletal phenotypes, indicating a critical requirement for Nf1 haploinsufficiency at a more primitive/progenitor stage of myeloid development in perpetuating osteolytic activity. We further identified p21Ras-dependent hyperphosphorylation of Pu.1 within the nucleus of Nf1 haploinsufficient myelomonocytic osteoclast precursors, providing a novel therapeutic target for the potential treatment of NF1 associated osteolytic manifestations.",
keywords = "animal models, cells of bone, diseases and disorders of/related to bone, genetic animal models, osteoclasts, osteoporosis",
author = "Rhodes, {Steven D.} and Hao Yang and Ruizhi Dong and Keshav Menon and Yongzheng He and Zhaomin Li and Shi Chen and Staser, {Karl W.} and Li Jiang and Xiaohua Wu and Xianlin Yang and Xianghong Peng and Mohammad, {Khalid S.} and Guise, {Theresa A.} and Mingjiang Xu and Feng-Chun Yang",
year = "2015",
month = "10",
day = "1",
doi = "10.1002/jbmr.2538",
language = "English (US)",
volume = "30",
pages = "1840--1851",
journal = "Journal of Bone and Mineral Research",
issn = "0884-0431",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Nf1 haploinsufficiency alters myeloid lineage commitment and function, leading to deranged skeletal homeostasis

AU - Rhodes, Steven D.

AU - Yang, Hao

AU - Dong, Ruizhi

AU - Menon, Keshav

AU - He, Yongzheng

AU - Li, Zhaomin

AU - Chen, Shi

AU - Staser, Karl W.

AU - Jiang, Li

AU - Wu, Xiaohua

AU - Yang, Xianlin

AU - Peng, Xianghong

AU - Mohammad, Khalid S.

AU - Guise, Theresa A.

AU - Xu, Mingjiang

AU - Yang, Feng-Chun

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Although nullizygous loss of NF1 leads to myeloid malignancies, haploinsufficient loss of NF1 (Nf1) has been shown to contribute to osteopenia and osteoporosis which occurs in approximately 50% of neurofibromatosis type 1 (NF1) patients. Bone marrow mononuclear cells of haploinsufficient NF1 patients and Nf1+/- mice exhibit increased osteoclastogenesis and accelerated bone turnover; however, the culprit hematopoietic lineages responsible for perpetuating these osteolytic manifestations have yet to be elucidated. Here we demonstrate that conditional inactivation of a single Nf1 allele within the myeloid progenitor cell population (Nf1-LysM) is necessary and sufficient to promote multiple osteoclast gains-in-function, resulting in enhanced osteoclastogenesis and accelerated osteoclast bone lytic activity in response to proresorptive challenge in vivo. Surprisingly, mice conditionally Nf1 heterozygous in mature, terminally differentiated osteoclasts (Nf1-Ctsk) do not exhibit any of these skeletal phenotypes, indicating a critical requirement for Nf1 haploinsufficiency at a more primitive/progenitor stage of myeloid development in perpetuating osteolytic activity. We further identified p21Ras-dependent hyperphosphorylation of Pu.1 within the nucleus of Nf1 haploinsufficient myelomonocytic osteoclast precursors, providing a novel therapeutic target for the potential treatment of NF1 associated osteolytic manifestations.

AB - Although nullizygous loss of NF1 leads to myeloid malignancies, haploinsufficient loss of NF1 (Nf1) has been shown to contribute to osteopenia and osteoporosis which occurs in approximately 50% of neurofibromatosis type 1 (NF1) patients. Bone marrow mononuclear cells of haploinsufficient NF1 patients and Nf1+/- mice exhibit increased osteoclastogenesis and accelerated bone turnover; however, the culprit hematopoietic lineages responsible for perpetuating these osteolytic manifestations have yet to be elucidated. Here we demonstrate that conditional inactivation of a single Nf1 allele within the myeloid progenitor cell population (Nf1-LysM) is necessary and sufficient to promote multiple osteoclast gains-in-function, resulting in enhanced osteoclastogenesis and accelerated osteoclast bone lytic activity in response to proresorptive challenge in vivo. Surprisingly, mice conditionally Nf1 heterozygous in mature, terminally differentiated osteoclasts (Nf1-Ctsk) do not exhibit any of these skeletal phenotypes, indicating a critical requirement for Nf1 haploinsufficiency at a more primitive/progenitor stage of myeloid development in perpetuating osteolytic activity. We further identified p21Ras-dependent hyperphosphorylation of Pu.1 within the nucleus of Nf1 haploinsufficient myelomonocytic osteoclast precursors, providing a novel therapeutic target for the potential treatment of NF1 associated osteolytic manifestations.

KW - animal models

KW - cells of bone

KW - diseases and disorders of/related to bone

KW - genetic animal models

KW - osteoclasts

KW - osteoporosis

UR - http://www.scopus.com/inward/record.url?scp=84942196007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942196007&partnerID=8YFLogxK

U2 - 10.1002/jbmr.2538

DO - 10.1002/jbmr.2538

M3 - Article

C2 - 25917016

AN - SCOPUS:84942196007

VL - 30

SP - 1840

EP - 1851

JO - Journal of Bone and Mineral Research

JF - Journal of Bone and Mineral Research

SN - 0884-0431

IS - 10

ER -